Release of tenofovir from carrageenan-based vaginal suppositories.
about
Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint AnalysisFirmness Perception Influences Women's Preferences for Vaginal Suppositories.On-demand microbicide products: design matters.Innovative sensory methods to access acceptability of mixed polymer semisoft ovules for microbicide applications.Designing and developing suppository formulations for anti-HIV drug delivery.
P2860
Release of tenofovir from carrageenan-based vaginal suppositories.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Release of tenofovir from carrageenan-based vaginal suppositories.
@ast
Release of tenofovir from carrageenan-based vaginal suppositories.
@en
Release of tenofovir from carrageenan-based vaginal suppositories.
@nl
type
label
Release of tenofovir from carrageenan-based vaginal suppositories.
@ast
Release of tenofovir from carrageenan-based vaginal suppositories.
@en
Release of tenofovir from carrageenan-based vaginal suppositories.
@nl
prefLabel
Release of tenofovir from carrageenan-based vaginal suppositories.
@ast
Release of tenofovir from carrageenan-based vaginal suppositories.
@en
Release of tenofovir from carrageenan-based vaginal suppositories.
@nl
P2860
P1433
P1476
Release of tenofovir from carrageenan-based vaginal suppositories.
@en
P2093
Gregory R Ziegler
Toral Zaveri
P2860
P304
P356
10.3390/PHARMACEUTICS6030366
P577
2014-07-04T00:00:00Z